AYOXXA

About:

AYOXXA is a biotech company commercializing innovative technology.

Twitter/X: AyoxxA

Top Investors: KfW, Wellington Partners, HTGF | High-Tech Gruenderfonds, Grazia Equity, b2venture

Description:

AYOXXA is a biotech company commercializing innovative technology developed at the National University of Singapore (NUS). AYOXXA’s patented technology platform is producing a new generation of biochips – merging biology with IT. This allows the biochip to accumulate large numbers of applications – measuring multiple protein markers for cancer, allergies, cardiovascular and infectious diseases – in a single test.

Total Funding Amount:

11.3M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cologne, Nordrhein-Westfalen, Germany

Founded Date:

2010-01-01

Contact Email:

info(AT)ayoxxa.com

Founders:

Andreas Schmidt, Dieter Trau

Number of Employees:

11-50

Last Funding Date:

2022-03-14

IPO Status:

Private

Industries: